Literature DB >> 21680060

[Electrical impedance tomography in acute lung injury].

J Riera1, P J Riu, P Casan, J R Masclans.   

Abstract

Electrical impedance tomography has been described as a new method of monitoring critically ill patients on mechanical ventilation. It has recently gained special interest because of its applicability for monitoring ventilation and pulmonary perfusion. Its bedside and continuous implementation, and the fact that it is a non-ionizing and non-invasive technique, makes it an extremely attractive measurement tool. Likewise, given its ability to assess the regional characteristics of lung structure, it could be considered an ideal monitoring tool in the heterogeneous lung with acute lung injury. This review explains the physical concept of bioimpedance and its clinical application, and summarizes the scientific evidence published to date with regard to the implementation of electrical impedance tomography as a method for monitoring ventilation and perfusion, mainly in the patient with acute lung injury, and other possible applications of the technique in the critically ill patient. The review also summarizes the limitations of the technique and its potential areas of future development.
Copyright © 2011 Elsevier España, S.L. y SEMICYUC. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21680060     DOI: 10.1016/j.medin.2011.05.005

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  2 in total

Review 1.  Electrical impedance tomography.

Authors:  Beatriz Lobo; Cecilia Hermosa; Ana Abella; Federico Gordo
Journal:  Ann Transl Med       Date:  2018-01

2.  Characterization of blunt chest trauma in a long-term porcine model of severe multiple trauma.

Authors:  K Horst; T P Simon; R Pfeifer; M Teuben; K Almahmoud; Q Zhi; S Aguiar Santos; C Castelar Wembers; S Leonhardt; N Heussen; P Störmann; B Auner; B Relja; I Marzi; A T Haug; M van Griensven; M Kalbitz; M Huber-Lang; R Tolba; L K Reiss; S Uhlig; G Marx; H C Pape; F Hildebrand
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.